They provide high-quality research services to the pharmaceutical and biotechnology industries, including protein production, purification, and biophysical characterization. Their expertise in structural biology enables drug screening, optimization, and development for their clients. Recently, Xtal BioStructures was acquired by Schrödinger, expanding their capabilities and resources in the field of structural biology.